NuProbe Global and Bionano Team to Co-Develop Testing Products
NuProbe Global and Bionano Genomics have entered into a procurement and collaboration agreement, for research and product development.
Read MorePosted by Chris Wolski | Sep 2, 2021 | Sequencing Systems |
NuProbe Global and Bionano Genomics have entered into a procurement and collaboration agreement, for research and product development.
Read MorePosted by Chris Wolski | Aug 31, 2021 | Cardiovascular |
Natera, Inc. has announced the validation and availability of its Prospera Heart transplant assessment test for heart transplant recipients.
Read MorePosted by Chris Wolski | Aug 30, 2021 | Diabetes & Metabolic Diseases |
Testing for, monitoring, and controlling diabetes continues to become more robust, cost-effective, and nuanced.
Read MorePosted by Chris Wolski | Aug 23, 2021 | Cardiovascular |
Cardiovascular genetic testing in children presents unique challenges, requiring pre- and post-test counseling with an individualized approach for families.
Read MorePosted by Chris Wolski | Aug 23, 2021 | Lung Cancer |
Researchers have developed novel artificial intelligence blood testing technology that detected over 90% of lung cancers from 800 samples.
Read More